Kelly Jackson

Kelly Jackson

Toxicologist

Kelly has worked part-time for bibra since 2013. After completing her PhD (examining mechanisms of cellular zinc homeostasis), she undertook a short visiting fellowship position at the Environmental Health Science and Research Bureau of Health Canada (exploring the regulation of microRNA expression in mice following acute toxicant exposure). She then spent 3 years working as a Research Scientist for a start-up biotech company in Canada, where she played a role in the development, validation and regulatory clearance of a medical diagnostic device.

At bibra, Kelly is involved in the production of chemical hazard and risk assessment profiles for various consumer products and chemical compounds, summarizing the most pertinent data on toxicology, physical and chemical properties, exposure levels, estimated intake and regulatory status. She is also experienced in writing reports summarising the pharmacological, pharmacodynamic and pharmacokinetic aspects of diverse products.

In her spare time, Kelly enjoys watching her little boy’s football team (and is forced to play football in the garden for at least 1 hour a day…). She also “enjoys” Les Mills classes at the gym and is a Newcastle United fan.

Kelly's case studies and blog posts

Medical devices and CE certification

Blog articles

A medical device placed on the EU market must have a CE (“Conformité Européenne”) certification and comply with the EU Medical Devices Regulation (MDR; Regulation (EU) 2017/745) [1] or the EU In Vitro Diagnostic Medical Devices Regulation (IVDR; Regulation (EU) 2017/746) [2]. Read our overview on the process, plus find out how we can help.

The Importance of Safety Pharmacology Testing of Human Pharmaceuticals

Blog articles

Progression of a new pharmaceutical/drug from the laboratory to clinical trials requires it to have both a recognised health benefit and an acceptably-low risk of inducing adverse effects. By identifying undesirable effects and their underlying mechanisms, safety pharmacology studies are an essential component of the drug development process. Here, we’ll review the importance of safety pharmacology testing in human pharmaceuticals.

Hazard characterisation of several e-liquid ingredients

Case study

The client is required to provide regulatory authorities with up-to-date toxicological information related to the ingredients used in their products. Bibra were provided with a list of several substances and asked to produce a hazard review (considering the requirements of the European Tobacco Products Directive, TPD2) for each.

Want to read more case studies and blog posts that Kelly has been involved in? Click below to read more.

Contact us